Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of Menstrual Cycle on Antiretroviral Pharmacokinetics
NCT00869960Phase 4Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- Mar 2009
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tenofovir, emtricitabine, atazanavir, ritonavir in human immunodeficiency virus infection (HIV), sponsored by University of Alabama at Birmingham. Started Mar 2009; status: completed.
02
Drugs
tenofoviremtricitabineatazanavirritonavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00869960.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00869960.